ALB and type 2 diabetes mellitus: Although we believe that these two effects are the major reasons for the clinically identified decreased albumin levels as a risk factor for T2DM, whether the protective effect of rMSA against lipotoxicity at the cellular level is also applicable to that of in vivo needs to be confirmed in future studies.